Perspectives on newborn screening for Fabry disease based on mothers' experiences in Japan

Noriko Sasaki1, Yoko Nakajima2, Yukari Hibino3

  • 1Matsunami Research Park, Kasamatsu, Gifu, Japan.

PubMed

Insights

Newborn screening for Fabry disease (FD) can cause maternal anxiety during the asymptomatic period. Support, like genetic counseling, can ease this burden and improve screening effectiveness.

Area of Science:

  • Genetics
  • Pediatrics
  • Psychology

Background:

  • Newborn screening (NBS) for Fabry disease (FD) enables early treatment but raises concerns about prolonged uncertainty for families.
  • Mothers, often heterozygous carriers and primary caregivers, are particularly affected by the psychological impact of asymptomatic FD diagnoses in their children.

Purpose of the Study:

  • To explore the experiences, emotions, and support needs of mothers whose children were diagnosed with FD via NBS.
  • To understand the psychological impact of the asymptomatic period on these mothers and identify areas for improved support.

Main Methods:

  • Qualitative study involving semistructured interviews with five mothers of children diagnosed with FD through NBS.
  • Analysis of interview data using the KJ (Kawakita Jiro) method, a bottom-up qualitative approach.

Main Results:

  • Mothers experienced a significant psychological burden due to monitoring for FD symptom onset.
  • This burden was mitigated by understanding disease onset timing, physician input, time, and personal coping mechanisms.
  • Mothers expressed a need for better disease information, empathy, and peer support, with mixed feelings about NBS discovery.

Conclusions:

  • Understanding mothers' experiences is crucial for effective FD NBS implementation.
  • Providing enhanced support, including genetic counseling and peer networks, can alleviate maternal anxiety and improve the overall NBS experience.
  • Addressing the psychological impact on caregivers is essential for optimizing early detection strategies in genetic diseases.